IMA
ImageneBio, Inc.
4.70$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.8% | -10.1% | -8.9% | -5.4% | -5.0% | -7.5% | -3.6% | +27.5% | -4.9% | -10.7% | +11.2% | |
| – | -11.0% | -9.8% | -7.3% | -5.2% | -10.1% | -8.0% | -15.4% | +49.0% | -4.9% | -13.0% | +15.7% | |
| – | -1.1% | -55.9% | -16.2% | +2.1% | -12.8% | -6.7% | +58.6% | +77.0% | -66.1% | +117.5% | +24.5% | |
| – | -10.9% | -10.3% | -7.6% | -5.1% | -9.9% | -8.3% | -16.1% | +49.1% | -46.8% | +54.7% | +16.2% | |
| – | – | – | – | – | – | – | – | – | +78.0% | – | – | |
| – | -20.6% | -21.9% | -16.1% | +0.9% | +5.6% | -19.2% | -18.5% | +105.1% | -5.7% | -32.7% | -25.3% | |
| – | -26.3% | -28.4% | -19.4% | +12.7% | +16.6% | -18.4% | -16.7% | +52.2% | +0.8% | -40.9% | -0.9% | |
| – | +2.6% | -3.2% | +7.3% | +6.2% | -3.5% | +2.9% | -1.5% | -43.6% | +4.7% | +1.9% | -17.1% | |
| – | -47.7% | -7.6% | -26.2% | +9.4% | -41.8% | -10.3% | -36.4% | +306.4% | -30.9% | -60.5% | +72.0% | |
| – | -9.3% | -8.5% | -8.0% | -6.0% | -6.2% | -6.1% | -2.0% | +20.6% | -4.8% | -7.4% | +15.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.1% | +0.9% | +0.0% | -65.2% | +0.7% | +0.0% | +70.7% | +254.3% | +31.1% | +0.3% | +44.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.